Your browser doesn't support javascript.
loading
Complete Response to Cetuximab Plus Paclitaxel Therapy in Nivolumab-Refractory Patients in Distant Metastasis of Squamous Cell Carcinoma of the Tongue: A Report of Two Cases.
Tachinami, Hidetake; Tomihara, Kei; Takatsuka, Danki; Ikeda, Atsushi; Yamada, Shin-Ichi; Noguchi, Makoto.
Afiliación
  • Tachinami H; Oral and Maxillofacial Surgery, Toyama University, Toyama, JPN.
  • Tomihara K; Oral and Maxillofacial Surgery, Graduate School of Medical and Dental Sciences, Niigata University, Niigata, JPN.
  • Takatsuka D; Oral and Maxillofacial Surgery, Toyama University, Toyama, JPN.
  • Ikeda A; Oral and Maxillofacial Surgery, Toyama University, Toyama, JPN.
  • Yamada SI; Oral and Maxillofacial Surgery, Toyama University, Toyama, JPN.
  • Noguchi M; Oral and Maxillofacial Surgery, Toyama University, Toyama, JPN.
Cureus ; 15(11): e49198, 2023 Nov.
Article en En | MEDLINE | ID: mdl-38130517
ABSTRACT
Herein, we report two cases of patients diagnosed with nivolumab-refractory distant metastatic squamous cell carcinoma of the tongue who were successfully treated with a combination of paclitaxel and cetuximab. Case 1 had controllable local recurrence and distant metastasis. Case 2 had controllable distant metastatic disease. Thus, demonstrating that some nivolumab-refractory patients with recurrent or distant metastatic oral squamous cell carcinoma may benefit from subsequent salvage chemotherapy.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cureus Año: 2023 Tipo del documento: Article